Japanese CRO CAC EXICARE Teams with Medidata to CRO CAC EXICARE Teams with Medidata to Improve Customers’ Clinical Trial Efficiency and Effectiveness Through Cloud ... Medidata Rave,
Post on 09-May-2018
Embed Size (px)
Japanese CRO CAC EXICARE Teams with Medidata to Improve
Customers Clinical Trial Efficiency and Effectiveness Through Cloud Technology
IT-Focused Japanese CRO Joins Medidata Partner Program to Meet Growing Asian Demand for Medidata Clinical Cloud
NEW YORK, N.Y. & TOKYO, JAPAN April 16, 2013 Japan-based contract research organization (CRO) CAC EXICARE has joined Medidata Solutions
(NASDAQ: MDSO) Partner Program to expand its services offerings to support
the Medidata Clinical Cloud. As a new Medidata Services Partner, CAC EXICARE is pursuing several accreditations across the Medidata cloud-based platform to
support clinical trials in all phases, including Japanese post-marketing surveillance studies. Medidatas innovative solutions for randomization and trial supply management (RTSM), electronic data capture and management, and
medical coding will be supported by CAC EXICARE.
CAC EXICARE is a 2012 spinoff from CAC, an extensive IT services organization that has been supporting operations of pharmaceutical companies for more than
40 years. With deep expertise applying technology to bring efficiencies to its customer base of more than 150 life science companies, including Japanese branches of global pharmaceutical corporations, CAC EXICARE supports all
phases of clinical development. At the request of many of their customers, CAC EXICARE decided to become a Medidata Services Partner and pursue
accreditation in Medidata Rave, the leading electronic data capture (EDC) and clinical data management (CDM) system, and is also pursuing accreditations in Medidata Balance (for RTSM) and Medidata Coder (for medical coding).
We are excited to partner with Medidata Solutions to further strengthen
our service offerings that bring efficiencies and effectiveness to clinical trials, said Koji Iwamoto, business development and planning deputy manager, CAC EXICARE. Our customers have seen the benefits of
Medidata Rave, including improved site productivity, data access and workflow, and anticipate the optimization advantages of the broader
Medidata Clinical Cloud. The nature of clinical research demands solutions that are globally accessible
and still meet regulatory and security requirements. Medidatas standards-based platform provides CAC EXICARE with a secure collaborative environment that is
configurable and flexibleincluding easily integrating with other systemsaccelerates study start-ups and enhances study execution.
With their commitment to bringing technology-based advantages to life science organizations, CAC EXICARE shares our vision to accelerate and
enhance clinical trial management and decision making through technology, said Steve Heath, vice president of channel sales at Medidata Solutions. We are delighted to welcome CAC EXICARE as a Medidata
Services Partner to help us serve the APAC regions increasing demand for
the Medidata Clinical Cloud, and are confident that their customers will derive value from it quickly.
Medidata first announced its channel partner program in April 2005 to enable
select CROs and other service providers to offer implementation services for Medidata Rave. Since then, the Medidata Partner Program has grown to include 38 partners in the U.S., Europe and Asia, ranging from smaller clinical
consultancies to large, global CROs. The program also now offers eight accreditations across the Medidata platform and supports partners with a variety
of on-demand resources to help them optimize sponsors clinical trials. Connect with Medidata:
Tweet this: Japanese IT-focused CRO CAC EXICARE joins @Medidata Partner Program to deliver cloud platform for Asian trials
http://bit.ly/14i8l7a Read our blog, Geeks Talk Clinical Follow us on Twitter: @Medidata
Find us on LinkedIn
About CAC EXICARE CAC EXICARE is an IT systems integrator with rich experience and knowledge
related to pharmaceutical R&D, as well as a CRO that provides contract services from clinical development to post-marketing surveillance. In April 2012, CAC Corporation split off its business unit of the clinical development operation and
IT support services, and the new spinoff company started its business as CAC EXICARE Corporation. For more than past 40 years, we have been supporting
operations of pharmaceutical companies by leveraging IT competence as our foundation.
About Medidata Solutions Medidata Solutions is a leading global provider of cloud-based clinical
development solutions that enhance the efficiency of customers clinical trials. Medidatas advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol
design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture
and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government
institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all
sizes developing life-enhancing medical treatments and diagnostics.
Geoff Curtis Edelman +1 312 233 1253
Hiroshi Watanabe BTO Business Planning Office Corporate Planning Dept.
CAC EXICARE +81 3 6667 8032